These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33568054)

  • 1. The unintended consequences of COVID-19 mitigation measures matter: practical guidance for investigating them.
    Turcotte-Tremblay AM; Gali Gali IA; Ridde V
    BMC Med Res Methodol; 2021 Feb; 21(1):28. PubMed ID: 33568054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
    Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
    Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
    Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Framework for Managing the COVID-19 Infodemic: Methods and Results of an Online, Crowdsourced WHO Technical Consultation.
    Tangcharoensathien V; Calleja N; Nguyen T; Purnat T; D'Agostino M; Garcia-Saiso S; Landry M; Rashidian A; Hamilton C; AbdAllah A; Ghiga I; Hill A; Hougendobler D; van Andel J; Nunn M; Brooks I; Sacco PL; De Domenico M; Mai P; Gruzd A; Alaphilippe A; Briand S
    J Med Internet Res; 2020 Jun; 22(6):e19659. PubMed ID: 32558655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unintended health and societal consequences of international travel measures during the COVID-19 pandemic: a scoping review.
    Klinger C; Burns J; Movsisyan A; Biallas R; Norris SL; Rabe JE; Stratil JM; Voss S; Wabnitz K; Rehfuess EA; Verboom B;
    J Travel Med; 2021 Oct; 28(7):. PubMed ID: 34369562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 research response to immediate demands: setting priorities with key stakeholders to enable health services research in NSW, Australia.
    Rankin NM; Nutbeam D; Levesque JF; Ko H; Jennings G; Walczak A; Jorm C
    J Health Organ Manag; 2024 Sep; 38(9):344-359. PubMed ID: 39308089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 response and mitigation: a call for action.
    Tangcharoensathien V; Singh P; Mills A
    Bull World Health Organ; 2021 Feb; 99(2):78-78A. PubMed ID: 33551498
    [No Abstract]   [Full Text] [Related]  

  • 9. Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic.
    Cundell T; Guilfoyle D; Kreil TR; Sawant A
    PDA J Pharm Sci Technol; 2020; 74(4):468-494. PubMed ID: 32467176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pandemic control: getting to the heart of unintended consequences.
    Wong B; El-Jack S; Armstrong G
    N Z Med J; 2020 Aug; 133(1520):153-156. PubMed ID: 32994610
    [No Abstract]   [Full Text] [Related]  

  • 11. Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities.
    ÓhAiseadha C; Quinn GA; Connolly R; Wilson A; Connolly M; Soon W; Hynds P
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant programs during COVID-19: Unintended consequences for health inequality.
    Sharma S; Lawrence C; Giovinazzo F
    Am J Transplant; 2020 Jul; 20(7):1954-1955. PubMed ID: 32314551
    [No Abstract]   [Full Text] [Related]  

  • 13. College Campuses and COVID-19 Mitigation: Clinical and Economic Value.
    Losina E; Leifer V; Millham L; Panella C; Hyle EP; Mohareb AM; Neilan AM; Ciaranello AL; Kazemian P; Freedberg KA
    Ann Intern Med; 2021 Apr; 174(4):472-483. PubMed ID: 33347322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equity Lens Protocol: Reflecting on Harms From the COVID-19 Response and Mitigation Strategies Implemented in a Local Public Health System.
    Fawcett S; Holt C; Solar-Hormazabal O; Eijkemans G; Partridge D; Jordan S; Bryan C; Zhu A; Williams AK; Hassaballa-Muhammad R; Hill E
    Health Promot Pract; 2024 Jul; 25(4):526-530. PubMed ID: 37177790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 40 health systems, COVID-19 (40HS, C-19) study.
    Braithwaite J; Tran Y; Ellis LA; Westbrook J
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 32991713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic.
    Perez Perez GI; Talebi Bezmin Abadi A
    Arch Med Res; 2020 Aug; 51(6):574-576. PubMed ID: 32446538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global regulatory agility during covid-19 and other health emergencies.
    Mak TK; Lim JC; Thanaphollert P; Mahlangu GN; Cooke E; Lumpkin MM
    BMJ; 2020 Apr; 369():m1575. PubMed ID: 32340997
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV prevention research and COVID-19: putting ethics guidance to the test.
    Rennie S; Chege W; Schrumpf LA; Luna F; Klitzman R; Moseki E; Brown B; Wakefield S; Sugarman J
    BMC Med Ethics; 2021 Jan; 22(1):6. PubMed ID: 33494754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.